Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)mediviewcurative Voice Therapy Coverage Update | O…
    Ask Trek AI about this page
    CurrentmediviewcurativePolicy MM-PNP-062

    Voice Therapy — Medical Necessity and Coverage Criteria

    Customize your policy alerts

    Sign up for mediviewcurative Policy MM-PNP-062 alerts

    Get alerted when Policy MM-PNP-062 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Policy governing medical necessity decisions for authorization requests for voice therapy services for members managed by the Medical Utilization Management (UM) Department.

    Policy Summary
    Payermediviewcurative
    PolicyVoice Therapy — Medical Necessity and Coverage Criteria
    Policy CodePolicy MM-PNP-062
    Change TypeNo material change
    Effective DateApr 12, 2024
    Next Review Date
    Key ActionObtain Medical UM authorization and document a listed medically necessary indication and clinical improvement within a 4‑week trial.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    8+Medically necessary indications listed
    4 weeksReassess after
    2Experimental items
    Transgender voice modCosmetic exclusion

    Coverage Criteria for Voice Therapy

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Initial coverage indications

    Covered when ANY of the following indications are present and therapy is intended to restore laryngeal speech production:

    Medically necessary indications: Essential voice tremor; following surgery or traumatic injury to the vocal cords; following treatment for laryngeal (glottic) carcinoma; muscle tension dysphonia (functional dysphonia); paradoxical vocal cord motion; spastic (spasmodic) dysphonia; symptomatic benign vocal fold lesions (cysts, nodules and polyps); vocal cord paralysis.

    From policy list of covered indications.

    Continuation / maintenance

    Continuation criteria

    Continued therapy requires improvement: Maintenance treatment where the patient's symptoms are not improving is considered not medically necessary. If no clinical benefit is appreciated after 4 weeks of voice therapy, the treatment plan should be re-evaluated. Further voice therapy is not considered medically necessary if the member does not demonstrate meaningful improvement in symptoms.4 weeks

    Therapy must show clinical benefit within the initial 4-week period.

    Voice therapy to feminize or masculinize the voice for transgender individuals is classified as cosmetic and is not covered. Specifically, voice therapy for male-to-female transgender individuals to feminize the voice or for female-to-male transgender individuals to masculinize the voice is considered not medically necessary. Providers should refer to related gender-affirming care policies when counseling members about treatment options.

    Megaphones or amplifiers used in the absence of an illness or injury do not meet the plan's definition of covered durable medical equipment. The policy notes that devices such as portable megaphones (e.g., ChatterVox, Mega Mite Megaphone) may be useful for communication but are not covered when provided for non-medical needs.

    Voice therapy provided solely to improve voice quality for occupational or recreational purposes (for example, public speaking or singing) is considered not medically necessary. Self-limited conditions such as acute laryngitis are also excluded from coverage when the intent is performance enhancement rather than treatment of a qualifying medical disorder.

    Pre-operative voice therapy intended to improve surgical outcomes for benign vocal fold lesions is considered experimental and investigational because its effectiveness has not been established. Similarly, voice therapy for vocal fold motion impairment following chemotherapy is classified as experimental/investigational. These indications are not covered under the policy.

    Coding and Trial Duration

    inv-07: Initial trial duration
    Initial trial duration4 weeks
    Re-evaluation requirementIf no clinical benefit after 4 weeks, the treatment plan should be re-evaluated before authorizing further therapy.
    Further therapy policyFurther voice therapy is not considered medically necessary if the member does not demonstrate meaningful improvement after the initial 4-week trial.

    Authorization and Documentation Requirements

    Prior Authorization

    Authorization required for covered indications

    Requests for voice therapy must be submitted for Medical Utilization Management (UM) authorization review; voice therapy is considered medically necessary only for the specified indications and must demonstrate clinical benefit within the initial treatment period.

    Step Therapy

    Re‑evaluate after 4 weeks if no improvement

    If no clinical benefit is appreciated after a 4‑week course of voice therapy, the treatment plan must be re-evaluated before authorizing additional therapy.

    • Initial trial duration: 4 weeks
    Documentation Required

    Provide supporting clinical documentation with authorization

    Authorization requests must be supported by documentation that the member's condition meets one of the listed medically necessary indications and by evidence of clinical improvement during therapy.

    • Document the specific medically necessary indication (e.g., essential voice tremor, post‑surgical/traumatic vocal cord injury, laryngeal carcinoma treatment, muscle tension dysphonia, paradoxical vocal cord motion, spastic dysphonia, symptomatic benign vocal fold lesions, vocal cord paralysis).
    • Provide objective or clinician-documented evidence of improvement during the authorized therapy period.
    Denial Risk

    Do not continue maintenance therapy without benefit

    Maintenance treatment without meaningful clinical improvement is not medically necessary; further voice therapy should not be authorized if the member does not demonstrate improvement after the re-evaluation following 4 weeks.

    • If symptoms are not improving, continuing therapy is considered not medically necessary.
    Denial Risk

    Transgender voice modification considered cosmetic

    Voice therapy to feminize or masculinize the voice for transgender individuals is considered cosmetic and is not medically necessary; such requests should be denied under the cosmetic exclusion.

    • Applies to male‑to‑female voice feminization and female‑to‑male voice masculinization.

    Background

    Voice therapy comprises therapeutic interventions aimed at restoring the ability to produce speech sounds from the larynx for specific medical indications. The policy defines medically necessary uses to include disorders such as essential voice tremor, postoperative or traumatic vocal cord injury, treatment sequelae of laryngeal carcinoma, muscle tension (functional) dysphonia, paradoxical vocal cord motion, spastic (spasmodic) dysphonia, symptomatic benign vocal fold lesions (cysts, nodules, polyps), and vocal cord paralysis. The goal of covered therapy is to restore laryngeal speech production and to produce demonstrable clinical improvement within the initial treatment period.

    Definitions

    inv-14: Voice therapy definition
    DefinitionTherapeutic interventions aimed at restoring the ability to produce speech sounds from the larynx for specified medical indications (e.g., essential voice tremor; post‑surgical or traumatic vocal cord injury; following treatment for laryngeal carcinoma; muscle tension dysphonia; paradoxical vocal cord motion; spastic dysphonia; symptomatic benign vocal fold lesions; vocal cord paralysis).
    Intended outcomeRestore laryngeal speech production and achieve meaningful improvement in voice-related symptoms.
    Exclusions from definitionVoice therapy provided for occupational or recreational voice improvement (e.g., public speaking, singing), self-limited conditions (e.g., acute laryngitis), or for cosmetic voice feminization/masculinization in transgender individuals is not considered medically necessary.
    Policy Summary
    Payermediviewcurative
    PolicyVoice Therapy — Medical Necessity and Coverage Criteria
    Policy CodePolicy MM-PNP-062
    Change TypeNo material change
    Effective DateApr 12, 2024
    Next Review Date
    Key ActionObtain Medical UM authorization and document a listed medically necessary indication and clinical improvement within a 4‑week trial.
    SourceLink
    On This Page
    Coverage Criteria for Voice TherapyCoding and Trial DurationAuthorization and Documentation RequirementsBackgroundDefinitions